Member access

4-Traders Homepage  >  Shares  >  Stock Exchange of Hong Kong  >  Lansen Pharmaceutical Holdings Co., Ltd.    0503   KYG5380M1033

End-of-day quote. End-of-day quote Stock Exchange of Hong Kong - 04/23
3.48 HKD   +5.45%
SummaryChart AnalysisCalendarCompanyFinancials 
Business Summary
Develops, manufactures and distributes Western pharmaceuticals

Lansen Pharmaceutical Holdings Ltd. is an investment holding company, which operates through its subsidiaries engages in the manufacturing and trading of pharmaceutical products.

It operates through two segments: Rheumatic Specialty Prescription Western Pharmaceuticals and Other Pharmaceuticals.

The Specialty Prescription Western Pharmaceuticals segment products include pafulin, liupuan, yisuojia and tuoshu.

The Other Pharmaceuticals segment provides indometacin cataplasm, bazhen keli, yinxingye pian, paracetamol orally and disintegrating tablets.

The company was founded on September 10, 2009 and is headquartered in Ningbo, China.
Sales per Businesses
20122013Delta
HKD (in Million)%HKD (in Million)%
Rheumatic Pharmaceuti466.3864.1%---
Other Pharmaceuticals261.5735.9%68.139.2% -283.95%
Specialty Pharmaceuticals--446.5660.6%-
Plant Extract And Healthcare Products--222.7730.2%-
Sales per Regions
20122013Delta
HKD (in Million)%HKD (in Million)%
China699.3496.1%696.1094.4% -0.47%
Rest of the World28.613.9%41.355.6% +30.82%
Officers and Executives
NameAgeOfficer SinceTitle
Bang Min Liu42-Chief Executive Officer & Executive Director
Stephen Burnau Hunt74-Chairman
Chi Hung Mui47-Chief Financial Officer & Secretary
Yi Liang49-Chief Technology Officer
Jin Yi Lee, MBA56-Deputy Chairman
Jun Tang54-Non-Executive Director
Fang Fang Tao43-Non-Executive Director
Pui Ling Yip55-Non-Executive Director
Kee Huen Chan62-Independent Non-Executive Director
Chiu Ping Tang65-Independent Non-Executive Director
Surperformance© rating of Lansen Pharmaceutical Hold
Overall rating In sector In country
Trading Rating - - -
Investor Rating - - -
Growth (Revenue) - - -
Valuation - - -
Finances
Profitability
Earnings quality
Business Predictability - - -
PER - - -
Potential - - -
Yield
Consensus - - -
7 days EPS revision - - -
4 months EPS revision - - -
1 year EPS revision - - -
4 months Revenue revision - - -
1 year Revenue revision - - -
More Ratings
Sector
Healthcare
Biotechnology / Pharmaceuticals
 Biotechnology / Pharmaceuticals
  Pharmaceuticals - Generic / Specialty
Advertisement
Sector Pharmaceuticals - Generic / Specialty
Trading RatingInvestor Rating
ASTRAZENECA PLC
ABBVIE INC
ALLERGAN, INC.
VALEANT PHARMACEU..
MCKESSON CORPORAT..
Sector Pharmaceuticals - Generic / Specialty
Company contact information
Lansen Pharmaceutical Holdings Ltd.
Building 14, Room 109
No. 818, Qiming Road
Ningbo, Zhejiang 315100

Phone : +86.574.8309.9777
Fax : +86.574.8309.9700
Web : www.lansen.com.cn
© 2014 Factset   
Dynamic quotes  
ON
| OFF